VCN BIOSCIENCES
VCN Biosciences specializes in the research and development of new treatments for tumors based on a technological platform using oncolytic viruses.
VCN BIOSCIENCES
Social Links:
Industry:
Biotechnology
Founded:
2009-01-01
Address:
Barcelona, Catalonia, Spain
Country:
Spain
Website Url:
http://www.vcnbiosciences.com
Total Employee:
11+
Status:
Active
Contact:
34 60 943 23 75
Email Addresses:
[email protected]
Technology used in webpage:
DreamHost Hosting Semantic UI
Similar Organizations
Animal Cell Therapies
Animal Cell Therapies engages in the research and development of stem cell treatments for acute and chronic diseases in companion animals.
Biomedical Tissues
Biomedical Tissues is specialised in the research and development of implantable medical devices for the regeneration of human tissue.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Current Advisors List
Current Employees Featured
Investors List
Grifols
Grifols investment in Funding Round - VCN Biosciences
Official Site Inspections
http://www.vcnbiosciences.com
- Host name: utopicus-usina.com
- IP address: 208.113.185.7
- Location: Brea United States
- Latitude: 33.9339
- Longitude: -117.8854
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 92821
More informations about "VCN Biosciences"
VCN Biosciences - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 34 60 943 23 75 VCN Biosciences specializes in the research and development of new treatments for tumors based on a …See details»
Theriva Biologics (formerly VCN Biosciences) | LinkedIn
Theriva is a clinical-stage immuno-oncology company developing oncolytic viruses intended to overcome the protective barrier surrounding solid tumors and selectively kill tumor cells.See details»
VCN - Ownership and Business Overview - Mergr
Www.vcnbiosciences.com. Profile Investors (2) Analytics VCN is a clinical-stage biotech company focused on developing a new oncolytic adenovirus (OV) platform designed for intravenous (IV) …See details»
VCN Biosciences - ASEBIO
VCN Biosciences mission is the development of new agents for the treatment of cancer based on oncolytic adenoviruses with high potency and selectivity. The company develops new …See details»
Synthetic Biologics Announces Planned Transformative
ROCKVILLE, Md., Dec. 14, 2021 /PRNewswire/ — Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company developing therapeutics designed to treat diseases …See details»
Synthetic Biologics Completes Acquisition of VCN Biosciences
Mar 11, 2022 – Expands pipeline into oncology with unique, clinical-stage oncolytic viruses optimized for intravenous administration – – Strong cash position to support multiple inflection …See details»
VCN Biosciences - Company Profile - Tracxn
Oct 22, 2024 VCN Biosciences - Oncolytic adenovirus-based therapies for cancer. Raised funding over 1 round from 1 investor. VCN Biosciences has 2889 competitors.See details»
VCN BIOSCIENCES - VentureRadar
Website: http://www.vcnbiosciences.com. VCN Biosciences mission is the development of new agents for the treatment of cancer based on oncolytic adenoviruses with high ...See details»
VCN Biosciences - Craft
VCN Biosciences is a company focused on the development of therapeutic approaches for tumor treatment. It uses an oncolytic adenovirus technology platform to design highly selective …See details»
Vcn Biosciences Sl Company Profile - Selligence
VCN Biosciences SL is a privately-owned company focused in the development of new therapeutic approaches for tumors that lack effective treatment.See details»
VCN Biosciences - ASEBIO
La misión de VCN Biosciences pasa por el desarrollo de nuevos agentes para el tratamiento del cáncer basados en los adenovirus oncolíticos que posean alta selectividad y potencia …See details»
VCN Biosciences - PitchBook
Information on acquisition, funding, investors, and executives for VCN Biosciences. Use the PitchBook Platform to explore the full profile.See details»
VCN Biosciences - Overview, News & Similar companies - ZoomInfo
Dec 14, 2021 Popular Searches VCN Biosciences Sl VCN Biosciences Vc & Co Barcelona Sl Vcnbiosciences SIC Code 87,873 NAICS Code 54,541 Show more. View Email Formats for …See details»
Manel Cascallo / VCN Biosciences open innovation case | PPT
Apr 30, 2014 Thank you! www.vcnbiosciences.com Dr. Manel Cascalló Chief Executive Officer VCN Biosciences SL www.vcnbiosciences.com Av de la Generalitat 152 08174 - Sant Cugat …See details»
Theriva Biologics SL (VCN生物科学有限公司) - 药物管线_专利_临床 …
- Reported topline data from the investigator sponsored Phase 1 trial of intravitreal VCN-01 in pediatric patients with refractory retinoblastoma; trial results were determined to be positive by …See details»
Theriva Biologics SL - Drug pipelines, Patents, Clinical trials - Synapse
Www.vcnbiosciences.com. Subsidiary Company | 2009 | Spain | 10-50 | www.vcnbiosciences.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. Translational …See details»
Synthetic Biologics Announces VCN Biosciences' VCN-01
Feb 8, 2022 VCN Biosciences lead product, VCN-01, is a oncolytic adenovirus with unique characteristics being studied in clinical trials for cancers for which there is no cure, including …See details»
Synthetic Biologics Completes Acquisition of VCN - GlobeNewswire
Mar 11, 2022 In addition, Synthetic Biologics agreed as a post-Closing covenant to commit to fund VCN’s research and development programs, including but not limited to VCN-01 PDAC …See details»
VCN-01 disrupts pancreatic cancer stroma and exerts antitumor …
11 Centro Integral Oncológico Clara Campal (CIOCC), Oña 10, 28050, Madrid, Spain [email protected] [email protected]. 12 Div. of Hematology and …See details»
VCN Health
We help bring the most appropriate American, European, and global healthcare products to patients that need them the most. Our clients are biotechnology, pharmaceutical, medical …See details»